JSR Life Sciences Acquires Selexis

(c) Lichtmeister/Shutterstock
(c) Lichtmeister/Shutterstock

JSR Life Sciences has acquired Swiss biotech Selexis for an undisclosed sum. The Geneva-headquartered company is the global leader in mammalian cell-line generation technologies and will boost JSR’s ability to develop and produce more high-quality biologics at a faster rate.

Selexis will be integrated within KBI Biopharma, a US-based contract development and manufacturing organization (CDMO) that JSR acquired in 2015.

“Combining KBI’s robust analytical, process development and reliable high-quality manufacturing capabilities with our Selexis SUREtechnology platform puts us in a position to offer current and future partners the ability to take their R&D programs from transfection to investigational new drug applications in less than nine months,” said Igor Fisch, CEO of Selexis. “By delivering the fastest timelines in the industry, our partners will benefit from substantial cost savings and patients will have access to critical drugs sooner.”

The two groups have a long history of collaboration, and KBI has performed development and/or manufacturing services using more than 15 different cell lines generated by Selexis since 2012.

Last month, KBI announced that it had agreed to buy the assets of San Diego-based Alliance Protein Laboratories, a leading analytical services company that specializes in biophysical characterization of biopharmaceuticals.

CDMO is also expanding its biopharmaceutical manufacturing capacities in Durham, North Carolina, and Boulder, Colorado, with completion due later this year.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.